BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 25, 2016
View Archived Issues
Light-activated quantum dots show promise as phototherapy for multidrug-resistant infections
Read More
Oxeia Biopharmaceuticals develops OXE-103 for concussion
Read More
Lysyl oxidase identified as a factor in thrombosis risk
Read More
FDA approves Botox for the treatment of lower limb spasticity in adults
Read More
FDA clears IND application for Agenus' anti-CTLA-4 and anti-GITR antibodies
Read More
GSK discontinues development of alitretinoin in U.S.
Read More
Phase II results indicate sustained expression with AAT deficiency gene therapy
Read More
FDA grants orphan drug designation to TRACON's anti-endoglin antibody
Read More
Broad Institute Genomic Services and Takeda partner to expand genomic insight into Ninlaro
Read More
Genentech and Xenon Pharmaceuticals patent Nav1.7 channel blockers
Read More
Immunocore's IMCgp-100 gets FDA orphan drug designation for uveal melanoma
Read More
Incyte discloses KDM1A inhibitors
Read More
ST Pharm presents tankyrase-1 inhibitors
Read More
Pharmacyclics reports BTK inhibitors
Read More
Takeda's H. influenzae type b conjugate vaccine approved in Japan
Read More
Bonviva tablet approved in Japan for the treatment of osteoporosis
Read More
bioTheranostics to spin out from bioMerieux
Read More
Apollo Therapeutics Fund established to advance preclinical drug R&D at U.K. universities
Read More
Expanded FDA approvals for Opdivo + Yervoy and single-agent Opdivo in melanoma
Read More
Shire's acquisition of Dyax complete
Read More
Merck & Co. studies [11C]MK-6884 as PET imaging agent
Read More
FDA grants orphan drug designation to mutant KIT inhibitor for mastocytosis
Read More